Association between C-reactive protein and features of the metabolic syndrome: a population-based study.

By M. Fröhlich, A. Imhof, G. Berg, W. Hutchinson, M. Pepys, H. Boeing, R. Muche, H. Brenner, W. Koenig. Diabetes Care, 2000

729 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

C-reactive protein: a critical update. (2003, background): “Raised base-line CRP values are also associated with many features of the insulin resistance or metabolic syndrome (33, 34), up to and including frank diabetes mellitus (35).”
Health risks associated with overweight and obesity (2007, background): “Increases in pro-inflammatory cytokines [interleukin 6, resistin, TNFα and C-reactive protein (CRP)] reflect overproduction by the expanded adipose tissue mass (13,14).”
The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. (2001, background): “Last, inflammation has been implicated as part of the insulin resistance syndrome (11,12).”
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. (2001, background): “In this regard, substantial experimental evidence and more recent crosssectional data suggest that interleukin 6 (IL-6) and C-reactive protein (CRP), 2 sensitive physiological markers of subclinical systemic inflammation, are associated with hyperglycemia, insulin resistance, and overt type 2 DM.(8-”